To determine the impact of early surgical intervention on long-term survival in patients with infective endocarditis (IE), charts of all patients who had IE from January 1987 through December 1996 were reviewed. A total of 252 patients with definite or possible IE were included. Forty-four patients (17.5%) had early surgery on median hospital day 2 (range, 0-30 days), and 208 patients (82.5%) received medical treatment alone. On multivariate analysis, several variables, including early surgical intervention, improved long-term survival rates (hazard ratio, 1.5; ), mainly in patients with Staphylococcus aureus etiology ( ). When patients P p .03 P p .04 with prosthetic devices were excluded, the median duration of survival for patients who had early surgery was 1150 months, compared with 61.5 months for patients in the medical group ( ). Early surgical P p .1 intervention compared with medical therapy alone is associated with increased short-and long-term survival rates in patients with IE, primarily when IE is caused by S. aureus.
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In the era before antibiotics, infective endocarditis (IE) was always fatal. More than 50 years after the introduction of antibiotic therapy, and more than 30 years after the first successful valve replacement, the reported early mortality rate of IE remains considerable (14%-31%), and late mortality rates after 5-year follow-up range from 25% to 60% [1] [2] [3] [4] .
Only a few large series on the long-term outcome of patients with IE have been reported, and even fewer have studied the impact of early surgery on long-term outcome [1, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The purposes of the present study were to determine long-term survival rates after an episode of IE, to delineate risk factors for mortality, and to focus on the impact of surgery performed during the active phase of IE on the long-term survival rate.
METHODS

Setting.
Rabin Medical Center-Beilinson Campus (Petach Tikvah, Israel) is a 900-bed tertiary care hospital. Schneider Children's Medical Center of Israel is a 300-bed tertiary care hospital. Both centers serve an urban population of ∼1,000,000 persons as both firstline and tertiary facilities. Similar to 5 additional large centers in Israel, they serve also as referral centers for other hospitals in the country.
Subjects. We reviewed the medical records of all patients who had a discharge diagnosis and/or postmortem findings compatible with IE and who were treated at the Beilinson campus or Schneider Children's Medical Center of Israel from January 1987 through December 1996.
The duration of follow-up, expressed in months, was defined as the interval from the first day of hospitalization to the day of death (as recorded in the Central Population Registry) or, if alive, up to 15 January 1998. Death of an Israeli resident is reported and registered in the Central Population Registry within 48 h.
For each patient, the following parameters were re- corded: age, sex, department of hospitalization, dates of admission and of diagnosis, duration from clinical onset to diagnosis, presumptive diagnosis at admission, date of discharge or in-hospital death, and duration of hospital stay. In addition, underlying heart abnormalities (rheumatic or degenerative valvular abnormalities, congenital defects, prosthetic valve, pacemaker, previous endocarditis, and/or injection drug addiction) as well as other associated diseases were recorded. Special attention was paid to the involved valve, responsible organism, clinical presentation, signs and symptoms, clinical course, and laboratory and echocardiographic findings. For patients who underwent surgery, the following variables were also recorded: timing of surgery, indication(s) for surgery, Gram stain and culture of the surgical specimen/s, and outcome of surgery.
Definitions. Modified Duke criteria for inclusion, as proposed by Li et al. [17] , were applied. Only definite and possible cases of endocarditis were included.
"Appropriate empiric antibiotic treatment" indicated that the infecting microorganism was susceptible in vitro to the drug administered during the 2 days after the first blood culture was performed and that the antibiotic was given intravenously and in an appropriate dosage (e.g., 8-12 g of cloxacillin per day). The duration of antibiotic therapy ranged from 4 to 6 weeks for patients with enterococcal or staphylococcal infections. "Early surgery" was defined as surgical intervention performed before completion of the course of antibiotic therapy. "Persistent infection" indicated the occurrence of bacteremia caused by the same microorganism while the patient had been receiving appropriate antibiotic therapy for at least 14 
RESULTS
During the 10 years of the study, there were 331 patients with a discharge diagnosis of IE. Of these, 79 patients were excluded from the study. The reasons for excluding these patients from the study were as follows: (1) the patients did not fit the modified Duke criteria [17] for "definite" or "possible" IE, (2) no pathologic evidence of IE was found at surgery, or (3) a firm alternative diagnosis explaining putative evidence of IE was found.
Two hundred and fifty-two patients were included in the study; 135 patients (54%) had "definite" endocarditis and 117 (46%) had "possible" endocarditis. There were 136 male patients and 116 female patients. The ratio of male patients to female patients was 1.17, and the median age was 64 years (range, 1 month-93 years). The median length of hospital stay was 26 days (range, 1-86 days). The median duration of followup was 33 months (range, 1-193 months).
Previous endocarditis had occurred in 31 patients (12.3%). There were 200 patients with and 52 patients (20.6%) without a known cardiac abnormality. There were no patients with a history of injection drug abuse. Among the 200 patients with known cardiac abnormalities, 59 (23.4%) had prosthetic valve endocarditis and 17 (7%) had pacemaker-associated endocarditis. One hundred and twenty-four patients (49%) had rheumatic, degenerative, or congenital heart defects. The responsible pathogens were viridans streptococci in 80 patients (32%), followed by Staphylococcus aureus, in 47 patients (19%); coagulase-negative staphylococci, in 27 patients (11%); Enterococcus species, in 15 patients (6%); and gram-negative bacteria or fungi, in 21 patients (8%). The latter included Haemophilus influenzae, Escherichia coli, Brucella melitensis, Klebsiella pneumoniae, Coxiella burnetii, Bacteroides species, and Candida albicans. In 62 patients (25%), no microorganisms were identified.
Forty-four patients (17.5%) were treated surgically during the active phase, and 208 patients (82.5%) received only medical treatment. Bacterial endocarditis was confirmed in every case of the surgical group either microbiologically and/or histologically. The median time from hospitalization to surgery was 2 days (range, 0-30 days). Indications for early surgery in 44 patients were as follows: persistent infection, in 15 cases (34%); heart failure, in 10 cases (23%); pacemaker endocarditis, in 7 cases (16%); and prosthetic valve dehiscence, in 8 cases (18%); bilateral femoral artery embolism, in 2 cases (5%); and fungal endocarditis, in 2 cases (5%). Most patients with persistent infection had perianular or intramyocardial abscess(es) at surgery. Table 1 details the demographic, clinical, laboratory, and microbiological comparisons between the 2 groups. Patients in the surgical group were significantly younger, with a median age of 58.5 years (range, 10-80 years) versus 65.5 years (range, 1.0-93.0 years) in the medical group ( ). P p .0001
The overall median duration of follow-up was 36.6 months (range, 0.03-150 months) in the surgical group and 30.6 months (range, 0.1-193 months) in the medical group. The rates of early surgical intervention were significantly higher in patients with a pacemaker or congenital or prosthetic heart disease ( ) as well as in patients with S. aureus endo-P p .006 carditis (
). P p .05 The 2 groups did not significantly differ with regard to vegetation size and rates of appropriate empiric antibiotic treatment. The frequency of neoplastic disease was 0% in the surgical group versus 7.2% in the medical group. Patients in the surgical group had higher serum creatinine levels ( ) as P p .04 well as blood urea nitrogen levels ( ) than did patients P p .0001 in the medical group.
Fatality rates and risk factors. A total of 128 patients (51%) died during the follow-up period. The in-hospital fatality rate was 16% (40 patients). In-hospital mortality rates for the medical and surgical groups were 18% and 11% ( ), P p NS respectively. The fatality rates were 25% at 6 months, 29% at 1 year, 50% at 6 years, and 60% at 10 years (figure 1). Table  2 details the factors associated with mortality on life-table analysis. The median cumulative duration of survival was 23.4 months in the fourth quartile of age (у75 years;
).
The median cumulative duration of survival of patients with streptococcal endocarditis was higher than that in other patients (  ; table 2 ).
Pneumonia as a presumptive diagnosis at admission, arrhythmia and dyspnea as presenting symptoms, elevated levels of blood urea nitrogen, and low levels of serum albumin were highly predictive of mortality (table 2) . The median cumulative survival of patients with tricuspid and combined aortic and mitral valve endocarditis was lower than that of patients with other involved valves ( ). Although the median duration P p .03 of survival of patients in the surgical group was higher than that in the medical group, this difference was not statistically significant on univariate analysis ( ; table 2; figure 2 ). P p .45 Stratified and multivariable analysis. The influence of early surgery versus medical treatment on long-term survival was tested by stratification of patients according to pathogens, underlying valvular disease (involved valve[s]), and quartiles of age. Early surgery significantly improved survival rates for patients with S. aureus endocarditis (figure 3; ) but not P p .04 for any other stratum.
We conducted a Cox regression analysis in which the independent variables were age, blood urea nitrogen level, serum creatinine level, serum albumin level, arrhythmia, and dyspnea at presentation; pneumonia as a presumptive diagnosis on admission; S. aureus as a pathogen; and the interaction between pathogen (S. aureus vs. others) and surgery (table 3; figure 4) . The interaction approached significance ( ). P p .08 A second analysis was conducted that used a 4-level variable for the pathogen (S. aureus, viridans streptococci, others, and none) and interaction between this variable and surgery with similar results (data not shown). We also repeated the multivariate Cox regression analysis, excluding patients in the medical group who died within 7 days after initiation of antibiotic therapy, in an attempt to eliminate those patients in the medical group who were rejected for surgery because they were too ill and were considered likely to die. These exclusion did not affect the results of the multivariate analysis (data not shown). In addition, when we analyzed the impact of early surgery on the long-term outcome of patients with native valve IE only, the mortality rate was still higher in the medical group. In the patients with native valve IE only, the median duration of survival for patients who had early surgery was 1150 months; for patients who received only medical treatment, it was 61.5 months (  ; table 4 ). P p .1 
DISCUSSION
We summarized our 10-year experience on 252 patients with definite or possible IE treated in our tertiary institutions. Special emphasis was put on risk factors for mortality and the effect of early surgical intervention on long-term prognosis. Early surgery was performed for 44 (17.5%) of our patients. The most common indication for surgical intervention was persistent infection and intracardiac abscesses. Early surgery was used more frequently in patients with a pacemaker or who had congenital prosthetic heart disease or S. aureus endocarditis. Patients in the surgical group were significantly younger but had higher levels of blood urea nitrogen and serum creatinine, which probably suggests a more severe disease. On the other hand, no other significant differences between the 2 groups were identified, with the exception of underlying malignancy, which was absent in the surgical group. Overall, we cannot rule out that comorbid conditions might have been a possible bias in patient selection for surgery. However, to minimize this potential group assignment bias, we repeated the Cox regression analysis after excluding those patients in the medical group who died within 7 days of appropriate antibiotic therapy. The results of that analysis were similar to the original results. Early surgery was a significant and independent predictor of long-term survival on multivariate analysis. In our study, the influence of early surgery on long-term survival was tested after patient stratification according to pathogens, involved valve, and age. The only significant difference in survival was found in patients with S. aureus endocarditis of both prosthetic and native valve, regardless of other variables. Early surgery also improved survival in patients with IE caused by other pathogens, but this difference did not reach statistical significance.
The early mortality rate was higher for patients who had endocarditis caused by S. aureus or Enterococcus species. Twenty-five percent of the patients with S. aureus endocarditis died within 2.5 months, and 25% of those with Enterococcus species endocarditis died within 2.1 months. The corresponding figure for patients with viridans streptococci was 30.8 months. These differences probably reflect mainly the ability of S. aureus and enterococci to cause a rapidly progressive and destructive cardiac infection.
Our study demonstrates that the long-term mortality rate owing to IE remains high. After a 10-year follow-up period, only 40% of our patients were alive. We were able to delineate several predictors for long-term mortality. In accordance with other investigators, we found that age [10, 11] , S. aureus infection [1, 11, 12] , aortic [14, 15] or double mitral-aortic valve involvement [12] , dyspnea, and/or arrhythmia at presentation [16] are independent factors for mortality.
In our study, "pneumonia" as a presumptive diagnosis at admission was an independent factor for long term mortality. This particular "risk factor" may actually reflect pulmonary congestion, heart failure, and/or advanced myocardial involvement by the infectious process, which has been well established in many studies elsewhere as a factor that adversely affects the prognosis [1, 10-13, 15, 16] . To our knowledge, involvement of the tricuspid valve has not been reported elsewhere as a risk factor for mortality, as was demonstrated on univariate analysis in the present study.
Since the first reported case of valve replacement in active IE in 1965 [18] , the role of surgical intervention in the management of this condition has become increasingly important. A few large series have looked at the impact of early surgery during the active phase of the disease on the long-term outcome [1, [10] [11] [12] [13] [14] [15] [16] .
Richardson et al. [1] showed a significant reduction in shortterm mortality rates with medical-surgical therapy in patients with both native and prosthetic valve endocarditis with moderate or severe heart failure, and in all patients with staphylococcal endocarditis, regardless of the patient's hemodynamic state. However, they found no significant difference in the longterm mortality rate between medical and surgical/medical groups in patients with native valve endocarditis [1] .
Croft et al. [14] reported significantly better overall survival rates for patients in the surgical group, as compared with the medically treated patients matched for severity of illness. However, they found no significant difference in the long-term survival rates between the 2 groups after discharge from the hospital.
Olaison et al. [10] showed that medical therapy alone had an increased relative risk of mortality, although it did not reach statistical significance, probably because of a small number of patients. In another study [19] , the mortality rate was significantly higher among medically treated patients than it was in the group of patients who underwent early surgical intervention. However, when patients who were too ill for surgery or who refused surgery were excluded, the mortality rates among medically treated patients decreased, and the difference in mortality rates between the 2 groups was no longer significant.
Valve replacement appears to have contributed to an improved survival rate, particularly in patients with congestive heart failure [1, 14] , aortic valve involvement [14] , S. aureus endocarditis [1, 11, 12] , and especially in patients with prosthetic valve S. aureus endocarditis [20] .
Our study had certain limitations. Because of the study's design, the 2 groups of patients were dissimilar. However, to minimize these differences, we used the Cox multivariable analysis. The survival rate was still higher in the surgical group even after exclusion (done to minimize possible bias in patients' selection for surgery) of those patients who died within 7 days of initiation of appropriate antibiotic therapy. Our findings favor early surgery in patients with S. aureus endocarditis. We were unable to define other groups of patients who would significantly benefit from combined surgical-medical therapy. A randomized prospective study is needed to determine the safety and efficacy of early surgical intervention in patients with IE, particularly in those patients infected with organisms other than S. aureus or who have additional risk factors for mortality. In addition, recruiting selected patients with S. aureus IE may also add valuable information regarding the appropriate timing of early surgery for these patients. Although assignment to medical or surgical therapy cannot be blinded, many unrecognized biases that influence patient selection for medical or surgical therapy should and can be eliminated. Alternatively, valuable information can be collected by establishing large, prospective databases in multiple medical centers by use of a uniform protocol. Such studies should be based on sensitive and reasonably specific criteria, such as those modified by Li et al. [17] for the diagnosis of IE.
In our opinion, our findings should not be interpreted as a suggestion that all patients with IE should undergo early surgery. However, we provide additional information to clinicians when making decisions concerning early surgical intervention in patients with IE, primarily in those with S. aureus IE.
